Neovascular age-related macular degeneration.

Abstract

With the advent of anti-VEGF therapy, the prognosis of choroidal neovascularization has changed dramatically.

Data from well-conducted clinical trials suggest that approved anti-VEGF drugs are effective and well tolerated.

Full Text

• DOI - Ophthalmologica. Journal international dNULLophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde (DOI)
• Swets Information Services - full-text online
• S. Karger AG, Basel, Switzerland - full-text online
• EBSCO - full-text online

Subjects

• Angiogenesis Inhibitors
• Antibodies, Monoclonal, Humanized
• Aptamers, Nucleotide
• Humans
• Recombinant Fusion Proteins
• Vascular Endothelial Growth Factor A
• Wet Macular Degeneration

Similar articles

• Identification and Analysis of in vivo VEGF downstream Markers Link VEGF Pathway Activity with Efficacy of Anti-VEGF Therapies. (2013-05-17)
• Peptidoglycan and muramyl dipeptide from Staphylococcus aureus induce the expression of VEGF-A in human limbal fibroblasts with the participation of TLR2-NFκB and NOD2-EGFR. (2012-08-14)
• Anti-VEGF therapy for glaucoma. (2010-02-09)
• Anti-VEGF therapy for the treatment of glaucoma: a focus on ranibizumab and bevacizumab. (2012-09-10)
• Regulation of vascular endothelial growth factor by melatonin in human breast cancer cells. (2012-08-16)
• A compartment model of VEGF distribution in blood, healthy and diseased tissues. (2008-10-07)
• Effect of VEGF and anti-VEGF compounds on retinal pigment epithelium permeability: an in vitro study. (2013-03-28)
• Systemic thromboembolic adverse events in patients treated with intravitreal anti-VEGF drugs for neovascular age-related macular degeneration. (2012-08-07)
• VEGF directly suppresses activation of T cells from ovarian cancer patients and healthy individuals via VEGF receptor Type 2. (2012-01-06)
• Neurovascular unit and the effects of dosage in VEGF toxicity: role for oxidative stress and thrombin. (2012-12-04)

Authors

• Daniele Veritti
• Valentina Sarao
• Paolo Lanzetta

Publication date

2012-04-20

Journal

Journal topics

• Ophthalmology

Language

Eng.

Copyright

Ophthalmologica. Journal international dNULLophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde

Department of Ophthalmology, University of Udine, Udine, Italy.

Release reference

Ophthalmologica. 2012 ;227 Suppl 1():11-20

Related books

• Books of Angiogenesis Inhibitors
• Books of Antibodies, Monoclonal, Humanized
• Books of Aptamers, Nucleotide
• Books of Ophthalmology
• Books of Recombinant Fusion Proteins
• Books of Vascular Endothelial Growth Factor A
• Books of Wet Macular Degeneration